Invicta Diagnostic IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Healthcare - Hospitals And Clinic sector. Socradamus Capital Private is the merchant banker of Invicta Diagnostic IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd August 2024.
Invicta Diagnostic IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Invicta Diagnostic IPO size is Rs [●] crores with IPO price of Rs [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Socradamus Capital Private Limited is the book-running lead manager of the Invicta Diagnostic IPO. Bigshare Services Private Limited is the Registrar and Market Maker is [●] for Invicta Diagnostic IPO.
Invicta Diagnostic IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Invicta Diagnostic IPO, based in Mumbai, operates in the Healthcare - Hospitals And Clinic sector with a focus on . The company is launching its SME UPCOMING IPO on the NSE EMERGE exchange, using the Book Building Issue method. Invicta Diagnostic IPO size is ₹ [●] Crores with fresh issue size of Rs [●] Crores and Offer for sale being Nil.
The IPO allotment date for Invicta Diagnostic IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Invicta Diagnostic IPO allotment status on the registrars website, Bigshare Services Private Limited. Invicta Diagnostic IPO refund dates are [●].
Invicta Diagnostic IPO is expected to be listed on [●].
The upper price band for the Invicta Diagnostic IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Invicta Diagnostic IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Invicta Diagnostic IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Invicta Diagnostic IPO is finalised.
The merchant banker for Invicta Diagnostic IPO is Socradamus Capital Private Limited . Socradamus Capital Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Invicta Diagnostic IPO RHP for further details.
The registrar for Invicta Diagnostic IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Invicta Diagnostic IPO through their official website or helpline.
Invicta Diagnostic IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Invicta Diagnostic IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Invicta Diagnostic Financial Review Page
Merchant Banker(s) of Invicta Diagnostic IPO: Socradamus Capital Private Limited
Invicta Diagnostic IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Invicta Diagnostic IPO listed at a listing price of against the offer price of .
The current market price of Invicta Diagnostic is .
Why Us?